Background. Respiratory infections are the leading cause of outpatient visits in the United States, but the etiology of many of these infections is unknown. Human metapneumovirus (hMPV) is a recently discovered virus that causes respiratory infections.
Respiratory infections are an important cause of morbidity and mortality in children [1] [2] [3] . Viral respiratory infections commonly cause bronchiolitis and pneumonia; bronchiolitis alone has been estimated to cause 154,365 hospitalizations/year among children !5 years old in the United States [4] . Influenza virus and respiratory syncytial virus (RSV) are estimated to cause 175-609 deaths/year among children !5 years old in the United States [5] . Respiratory viruses are also associated with exacerbations of chronic conditions, such as cystic fibrosis and asthma, and cause severe infections in patients with bronchopulmonary dysplasia, immune suppression, and congenital heart disease [6] [7] [8] [9] [10] [11] [12] .
In specimens obtained from many patients who have an apparent respiratory infection, no bacteria or virus is detected. In children with community-acquired pneumonia, an etiologic agent can be detected in only 43%-85% of cases [13, 14] . The lack of an etiologic agent in the remaining cases may be due to imperfect sensitivity of the tests used or may be due to unknown or newly discovered organisms that are not detected by current methods. A better understanding of the pathogenesis of these unclassified infections is critical to the development of appropriate interventions, including vaccines and infection control measures, to reduce respiratory infections.
Human metapneumovirus (hMPV) is a recently discovered virus that causes respiratory infections [15] . hMPV is a member of the family Paramyxoviridae, which also includes RSV, measles virus, and mumps virus. Among viruses known to infect humans, hMPV is most closely related to RSV [15, 16] . hMPV has been detected in specimens obtained from patients in The Netherlands, Canada, Finland, the United Kingdom, Australia, France, and the United States [15, [17] [18] [19] [20] [21] [22] [23] [24] [25] .
To investigate the role of hMPV in respiratory infections in children in the United States, we performed retrospective testing of respiratory specimens submitted to the clinical virology laboratory at Children's Hospital Boston (Boston, MA) over the course of 23 months. The hMPV results were compared with the results of routine clinical testing for other respiratory viruses.
MATERIALS AND METHODS

Study design.
We performed retrospective testing for hMPV on all available respiratory specimens obtained from children р18 years old and submitted for virological testing, between 1 October 2000 and 31 August 2002, at Children's Hospital Boston. A database, including patient identifying number, age, date of specimen collection, specimen type, tests ordered, and results of clinical virological testing, was generated from hospital computer records. Permission to test the specimens for hMPV and perform a data and chart review was obtained from the Committee on Clinical Investigation at Children's Hospital Boston. Human experimentation guidelines of the US Department of Health and Human Services and of Children's Hospital Boston were followed.
Clinical virology assays. Specimens were tested for viruses by use of viral culture and/or direct immunofluorescence (DFA) with antibodies specific for the viruses. Viral culture was performed in 2 tubes each of rhesus monkey kidney (Viromed Laboratories), Hep-2 (Diagnostic Hybrids), and human embryonic lung cells (BioWhitaker). Cultures were observed for 3 weeks for cytopathic effect and were tested for hemadsorption with guinea pig red blood cells (Viromed Laboratories). DFA was performed to test cultures suspected of containing a virus because of hemadsorption or cytopathic effect. DFA was performed directly on patients' specimens by use of antibodies against RSV (Trinity Biotech); influenza A and B viruses (Dako); adenovirus (Chemicon International); and parainfluenza virus (PIV) 1, PIV2, and PIV3 (Zymtex); as ordered by the physician. DFA for RSV and PIV3 could be ordered without a culture. Other available tests were DFA for RSV and PIV3 with viral culture, DFA for all 7 viruses with viral culture, and viral culture alone. For data analysis, any test that included culture was considered to test for RSV, influenza A virus, influenza B virus, adenovirus, PIV1, PIV2, and PIV3.
Reverse-transcription polymerase chain reaction (RT-PCR) assay for hMPV. After routine testing in the virology laboratory at Children's Hospital Boston, remaining specimens were frozen at Ϫ80ЊC. These specimens were tested for hMPV. RNA was purified by use of the QIAamp Viral RNA Mini Kit (Qiagen). Specimens were tested for hMPV by use of RT-PCR with primers for the F-gene (5 -CTTTGGACTTAATGACAGATG-3 [forward, bases 653-673] and 5 -GTCTTCCTGTGCTAACT-TTG-3 [reverse, bases 1083-1102]) using the Access RT-PCR System (Promega) [17] . Optimized conditions were 2 mmol/L MgSO 4 with thermal cycling of 45 min at 48ЊC; 2 min at 94ЊC; 40 cycles of PCR for 30 s, 1 min, and 2 min at 94ЊC, 55ЊC, and 68ЊC, respectively; and 7 min at 68ЊC. A second RT-PCR was used for confirmation. The primers amplified a conserved 302-bp region of the N-gene (5 -ACACCCTCATCATTGCA-ACA-3 [forward, bases 106-126] and 5 -GCCATTGTTTTCC-TTGCTTC-3 [reverse, bases 388-407]). The conditions were the same as those for F-gene RT-PCR, except that the annealing temperature was 59ЊC. The RT-PCR product of initial isolates was sequenced by use of the Mega BACE 1000 DNA analysis system. The sequences were 198% homologous to those of hMPV in the GenBank database [16] .
To create a positive control for the hMPV assay, an RT-PCRpositive specimen was grown for 3 weeks in rhesus monkey kidney cells [15] . RNA was prepared from supernatant and subjected to RT-PCR with the F-gene primers, and the resulting product was sequenced. The product was 198% homologous to the sequence of hMPV in the GenBank database [16] . Every run of RT-PCR included a positive control and a negative control (no RNA).
The hMPV F-and N-gene primers did not cross-react with RSV, influenza A and B viruses, PIV1, PIV2, PIV3, or adenovirus. Each virus specimen yielded products of the appropriate size when tested with primers specific for that virus, demonstrating that nucleic acid was present (PIV1 and PIV2 primer sequences are available from the authors upon request) [26, 27] .
Chart review. Patients' and hospital records were examined to determine the clinical manifestations of hMPV infection and any underlying conditions of patients with this virus. Two of the investigators (M.E.H. and A.J.M.) conducted the chart review by use of a structured instrument. Diagnoses were recorded on the basis of ICD-9 codes and text descriptions, which are standardized. The lead investigator determined the acute respiratory diagnosis that led to the collection of the specimen containing hMPV on the basis of the attending physician's note. The chart review instrument focused on underlying conditions that make patients susceptible to more-significant RSV infection, because this is the virus most closely related to hMPV. These conditions include asthma, cardiac malformation, and premature birth in children !2 years old [8, 9, 28] .
Statistics. The frequency of hMPV testing and the prevalence of hMPV in those tested were compared across categories of sex and age of the patient and season and year in which the specimen was obtained, by simple and multiple logistic regression. A repeated-measures logistic model was employed to adjust for multiple sampling from individual patients, using a compound-symmetric covariance structure (equal correlation among all of a given patient's results). SAS software (SAS Institute) was used for all computations.
RESULTS
Characteristics of patients and specimens tested. During the study period, 2377 respiratory specimens were submitted for viral testing. Of these specimens, 1257 (53%) were frozen and were available for subsequent hMPV testing. All of the 2377 specimens were tested for RSV and PIV3, and 1619 (68%) were also tested for influenza virus, PIV1, PIV2, and adenovirus. Approximately equal numbers of specimens were submitted in the 2000-2001 and 2001-2002 periods, with most specimens submitted during winter and the fewest submitted during summer (table 1) . Specimen sources included nasopharyngeal aspirates (62%), bronchoalveolar wash specimens (11%), respiratory aspirates not otherwise specified (8%), tracheal specimens (6%), sputum (4%), nasal discharge (3%), and other specimens (6%).
Many patients had 11 specimen submitted. Of the 2377 specimens, 70.9% were from patients who had only 1 specimen submitted, and 95.6% were from patients who had р4 submitted. The remaining patients had 5-24 specimens submitted. After accounting for repeat specimens from the same patients, specimens from 868 patients were tested for hMPV, specimens from 1433 patients were tested for RSV and PIV3, and specimens from 1012 patients were tested for the other viruses.
Specimens tested for hMPV did not differ from those not tested for hMPV, with regard to the sex of the patient or the period in which the specimen was obtained (2000-2001 or 2001-2002) (table 1 ). However, specimens tested for hMPV were more likely to be from older children (aged 25-216 months) and from fall and winter seasons than were those not tested.
Occurrence of viruses in respiratory specimens. RSV was detected most frequently, followed by hMPV, influenza virus, PIV3, adenovirus, and PIV1 (table 2) . Comparisons between the frequency of occurrence between the different viruses should be interpreted with caution, because the assay for hMPV was a nucleic acid amplification assay (RT-PCR), whereas other viruses were detected by use of DFA, culture, or both. Nucleic acid amplification is generally more sensitive for respiratory viruses than are conventional methods [29] [30] [31] [32] [33] . Since different numbers of patients were tested for some of the viruses, the percentage of patients who had at least 1 positive specimen for each virus is also shown. The percentage of patients with each virus follows the same order as the percentage of specimens with each virus.
Four patients had hMPV detected twice. Two patients had positive specimens on sequential days. One patient had a second positive specimen 8 days after the first positive specimen. The fourth patient was a 16 month-old-boy with immunodeficiency due to purine nucleoside phosphorylase deficiency. His first hMPV-positive specimen was obtained when he had fever and cough. A specimen obtained 27 days after this hMPV-positive specimen was obtained did not have detectable hMPV. He underwent a bone marrow transplant 44 days after the initial hMPV-positive specimen was obtained. A specimen obtained 15 days after the bone marrow transplant, when his white blood cell count was low (70 cells/mm 3 ), was again found to be positive for hMPV. A specimen obtained 20 days after this second positive specimen, when his white blood cell count had increased to 2300 cells/mm 3 , did not have detectable hMPV. Over the following 51 days, 3 more specimens were obtained, and none had detectable hMPV. His recovery was complicated by iron deficiency and graft-versus-host disease, but he was discharged 194 days after the transplant.
Epidemiological characteristics of hMPV infection. The seasonal distribution of hMPV infection was similar to those of RSV and influenza virus infections (figure 1). Most of the infections with these viruses occurred in December through April, with peak occurrence in January and February. In both The age distributions of hMPV, RSV, and influenza virus infections differed (figure 2). A greater proportion of RSV infections than hMPV or influenza infections occurred in children р2 months old. More than one-half of the cases of both hMPV and RSV occurred in children 3-24 months old. Few of the cases of influenza occurred in the youngest children, and the percentage of cases increased with age.
To evaluate factors associated with hMPV infection, we created a logistic regression model that included the sex and age of the patient and the period (2000-2001 or 2001-2002) and season in which the specimen was obtained (table 3) . hMPV was more common among patients 3-24 months old than among younger or older patients and was most common in winter and spring and less common in summer and fall. Neither the patient's sex nor the year in which the specimen was obtained was significantly associated with hMPV infection.
Clinical characteristics of hMPV infection. The underlying conditions and diagnoses of patients with hMPV infection are shown in table 4. Sixty-three percent of the patients had at least 1 of these underlying conditions, whereas 37% did not. Of those patients with underlying conditions, 26% had 11. Nearly all the patients with hMPV infection were admitted to the hospital, and many required oxygen inhalation therapy. A smaller proportion of patients with no underlying condition or with asthma as the sole underlying condition needed oxygen inhalation therapy than did those with cardiac malformations, premature birth, or multiple underlying conditions.
In addition to the underlying conditions shown in table 4, 5 patients had bronchopulmonary dysplasia. All of these children were born prematurely; 3 were diagnosed with bronchiolitis, and 2 were diagnosed with an upper respiratory infection. An additional 4 patients had other chronic respiratory conditions, including pulmonary hemosiderosis, pulmonary hypertension, hyaline membrane disease, and previous transplant for pulmonary hypertension. One patient with purine nucleoside phosphorylase deficiency is discussed above. Most patients with hMPV infection (89%) had a diagnosis consistent with viral respiratory infection (bronchiolitis, respiratory distress, pneumonia, or upper respiratory infection). A total of 3 patients were diagnosed with otitis media; for 1 patient, this was the primary diagnosis, whereas the other patients had either pneumonia or bronchiolitis as the primary diagnosis.
Mixed viral infections, including hMPV, occurred in 3 pa- tients. Two patients with a diagnosis of bronchiolitis had both hMPV and RSV. Both of these patients also had asthma and no other underlying condition. One patient, a 10-month-old girl with an 8-month history of cough, had hMPV, adenovirus, and cytomegalovirus. Her condition was significantly improved 1 month after collection of this specimen.
DISCUSSION
Our finding that most (94.8%) of the patients with hMPV infection were infected with hMPV alone supports the hypothesis that hMPV causes significant respiratory infections. Since viruses other than hMPV were detected by use of viral culture or DFA, which are less sensitive than RT-PCR, there may be more mixed viral infections than our data suggest; however, even with this caveat, it is very likely that symptomatic infections with hMPV often occur in the absence of other respiratory viruses. Since we tested for hMPV in all available specimens, not just specimens lacking other viruses, these data suggest that symptomatic hMPV infections in children occur in the absence of other viruses. The finding that 6.2% of the patients had detectable hMPV is comparable to results of previous results. Studies in the United Kingdom, France, Australia, and the United States, which included only specimens previously shown to lack other respiratory viruses, found hMPV in 2.2%-9.7% of the specimens [19] [20] [21] 24] . A study of adults in the United States found hMPV in 4.5% of patients tested [22] . Boivin et al. screened specimens by cytopathic effect and found that 2.3% of respiratory specimens submitted for virological testing to a regional laboratory in Canada were positive for hMPV [34] . Because screening for hMPV by cytopathic effect in culture is likely to be less sensitive than RT-PCR performed directly on specimens, this may be an underestimate of the level of hMPV infection. A study performed in The Netherlands found hMPV in 7% of specimens from children and adults tested for respiratory viruses [25] .
We found that the proportion of patients with hMPV infection is significantly higher among children 3-24 months old than among younger or older children. The initial description of hMPV included isolates from 26 patients, 25 of whom were !5 years old [15] . Our results are comparable to those of Freymuth et al. [21] and Esper et al. [24] , who tested for hMPV in respiratory specimens from children who were negative for other respiratory viruses. In both of those studies, more than one-half of the cases of hMPV occurred in children 3-24 months old. Similarly, most specimens with detectable hMPV were from children !2 years old in a study from The Netherlands [25] . A study in the United Kingdom also found that hMPV commonly infects young children, although adults have also been found to have this virus [19] .
The occurrence and severity of RSV and influenza virus infections in children is higher in boys than girls [35, 36] . Some studies have found a higher proportion of patients with hMPV infection among boys than girls [25, 37] , whereas others have not [38] . We found a higher percentage of patients with specimens having detectable hMPV among boys than girls (6.5% and 5.1%, respectively), but this finding was not statistically significant. Because the present study gathered clinical data retrospectively, definitive determination of the severity of hMPV infection in males and females awaits prospective studies.
The seasonal occurrence of hMPV infection largely overlapped with that of RSV and influenza virus infections, although, in both years, RSV infection appeared earlier during the winter than did infection with the other 2 viruses. A small number of infections with hMPV did occur outside of the peak of hMPV infections in January through March, including cases in September, October, April, and May. In contrast, influenza and RSV infections appeared to have more-regular seasonal occurrence, although this was not evaluated statistically. The present study included 133 specimens obtained during summer, only 0.6% of which contained hMPV. These and other data demonstrate that, although hMPV infection occurs primarily during the winter, it also occurs during other seasons [15, 17-21, 24, 25] .
Most patients with hMPV infection have diagnoses similar to those associated with RSV infection [18, 21, 24, 25, 34, 38] . In the present study, the single most common diagnosis in patients with hMPV infection was bronchiolitis, which is frequently associated with RSV [39] . Bronchiolitis caused by hMPV may be less severe than that caused by RSV in some studies; however, prospective data are not yet published [25, 38] . Bronchiolitis caused by mixed infections with hMPV and RSV may be more severe than that caused by infection with either virus alone [40] .
The present study included all available specimens submitted to the virology laboratory at this tertiary-care hospital and included a retrospective chart review. This design has at least 3 limitations. First, the specimens were ordered at the discretion of health-care providers, so consistent rules for patient inclusion could not be used. Second, there may be variation in the availability of specimens between groups of patients or seasons. Third, the clinical data should be interpreted with some caution, because a contemporaneous data collection tool was not used. For this reason, we have focused on underlying conditions and principle acute respiratory diagnosis of patients with hMPV infection, rather than manifestations (signs and symptoms) of illness, which may be subject to more variability in data recording. The diversity of the age of the patients allowed us to make the important observation that peak occurrence of hMPV infection was in 3-24-month-old children. However, because the study population was drawn from a children's hospital, it likely included a higher than representative proportion of children with underlying chronic conditions. Studies of defined cohorts of patients will be required to estimate the effect of hMPV infection relative to other respiratory viruses in general populations.
